Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Phibro Animal Health (PAHC) over the last 10 years, with Q1 2022 value amounting to $40.5 million.

  • Phibro Animal Health's Shares Outstanding (Weighted Average) rose 5.19% to $40.5 million in Q1 2022 from the same period last year, while for Mar 2022 it was $40.5 million, marking a year-over-year increase of 5.19%. This contributed to the annual value of $40412.0 for FY2019, which is 57.49% up from last year.
  • Latest data reveals that Phibro Animal Health reported Shares Outstanding (Weighted Average) of $40.5 million as of Q1 2022, which was up 5.19% from $40.5 million recorded in Q4 2021.
  • Phibro Animal Health's 5-year Shares Outstanding (Weighted Average) high stood at $40.5 million for Q3 2021, and its period low was $40181.0 during Q2 2018.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $40.5 million (2019), whereas its average is $32.4 million.
  • As far as peak fluctuations go, Phibro Animal Health's Shares Outstanding (Weighted Average) skyrocketed by 10096398.96% in 2018, and later changed by 0.0% in 2020.
  • Quarter analysis of 5 years shows Phibro Animal Health's Shares Outstanding (Weighted Average) stood at $40.4 million in 2018, then rose by 0.18% to $40.5 million in 2019, then changed by 0.0% to $40.5 million in 2020, then increased by 0.12% to $40.5 million in 2021, then changed by 0.0% to $40.5 million in 2022.
  • Its Shares Outstanding (Weighted Average) was $40.5 million in Q1 2022, compared to $40.5 million in Q4 2021 and $40.5 million in Q3 2021.